Volume 18, no. 10, p. 6090–6101, 1998. Page 6090, article byline, line 2: The names should read as shown above.
. 1998 Dec;18(12):7602.
ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network
Ronit Pinkas-Kramarski
1, Maya Shelly
1, Bradley C Guarino
1, Ling Mei Wang
1, Ljuba Lyass
1, Iris Alroy
1, Maurizio Alimandi
1, Angera Kuo
1, James D Moyer
1, Sara Lavi
1, Miriam Eisenstein
1, Barry J Ratzkin
1, Rony Seger
1, Sarah S Bacus
1, Jacalyn H Pierce
1, Glenn C Andrews
1, Yosef Yarden
1
Ronit Pinkas-Kramarski
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Ronit Pinkas-Kramarski
Maya Shelly
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Maya Shelly
Bradley C Guarino
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Bradley C Guarino
Ling Mei Wang
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Ling Mei Wang
Ljuba Lyass
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Ljuba Lyass
Iris Alroy
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Iris Alroy
Maurizio Alimandi
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Maurizio Alimandi
Angera Kuo
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Angera Kuo
James D Moyer
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by James D Moyer
Sara Lavi
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Sara Lavi
Miriam Eisenstein
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Miriam Eisenstein
Barry J Ratzkin
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Barry J Ratzkin
Rony Seger
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Rony Seger
Sarah S Bacus
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Sarah S Bacus
Jacalyn H Pierce
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Jacalyn H Pierce
Glenn C Andrews
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Glenn C Andrews
Yosef Yarden
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Find articles by Yosef Yarden
1Departments of Molecular Cell Biology, Structural Biology, and Membrane Research and Recognition, The Weizmann Institute of Science, Rehovot 76100, Israel; Pfizer Central Research, Groton, Connecticut 06340; The National Cancer Institute, Bethesda, Maryland 20892; Advanced Cellular Diagnostics, Inc., Elmhurst Illinois 60126; and Amgen Center, Thousand Oaks, California 91320
Copyright © 1998, American Society for Microbiology
PMCID: PMC109341
This corrects the article "ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network" on page 6090.